The president of an organisation conducting research into traumatic brain injuries has hailed the latest work in the stem cell (SC) treatment arena.
Chief executive officer at Stem Cell Therapeutics Dr Alan Moore, stated it was an "exciting and interesting" time for this area of medicine.
He made his comments before appearing on a panel discussion about the commercialisation of this type of treatment at this year's World SC Summit in Baltimore.
The meeting saw Dr Moore join 124 other presenting experts, with advanced science and regulation issues on the agenda.
"I feel our drug-based treatment offers a unique alternative to stem cell based therapies for regenerative medicine," he remarked.
His firm is currently ascertaining the possibility of using SCs to treat other illnesses such as multiple sclerosis and Alzheimer's disease
In related news, Truman Veterans Hospital recently commented to the Missourian on brain injuries, noting a number of strains of the ailment can affect soldiers on the battlefield.
News from Serious Law, specialist traumatic brain injury solicitors